# AMAP102 - Safety, Tolerability and Pharmacokinetics in Healthy Subjects

> **NCT00995605** · PHASE1 · TERMINATED · sponsor: **AnaMar AB** · enrollment: 40 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** AMAP102

## Key facts

- **NCT ID:** NCT00995605
- **Lead sponsor:** AnaMar AB
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-04
- **Primary completion:** 2009-08
- **Final completion:** 2009-08
- **Target enrollment:** 40 (ACTUAL)
- **Why stopped:** Reached sufficient pharmacokinetic exposures
- **Last updated:** 2009-10-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00995605

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00995605, "AMAP102 - Safety, Tolerability and Pharmacokinetics in Healthy Subjects". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00995605. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*